The global demand for Antibody Production Market is presumed to reach the market size of nearly USD 59.63 BN by 2030 from USD 16.39 BN in 2022 with a CAGR of 17.52% under the study period 2023 - 2030.
Antibody production refers to the production of cells by the immune system, which is carried out by the B cells. Antibodies are responsible for destroying threats like bacteria and viruses which infect the body and, thus, prevent any illness. Therapies, medications, and vaccines are provided to boost antibody production in the body.
The rising prevalence of infections, viruses, and other diseases like cancer, rheumatoid and chronic diseases are factors driving the market growth of antibody production. Growing investments by medical research centers for research and development projects and technological advancements for new launches are expected to propel the market growth of antibody production. Numerous pharmaceuticals are shifting towards biopharma which may drive the market growth of antibody production. Furthermore, the growing use of targeted therapies is anticipated to expand the overall market growth of antibody production. The rise in government incentives for antibody production is projected to drive market growth. On the contrary, the overall cost of antibody production and strict government policies for the approval of the therapies and drugs may further hamper the market growth of antibody production.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antibody production. The growth and trends of antibody production industry provide a holistic approach to this study.
This section of the antibody production market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Type
By Process
By End-Use
This section covers the regional outlook, which accentuates current and future demand for the Antibody Production market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antibody production market include Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, and FiberCell Systems Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Avail customized purchase options to meet your exact research needs: